Skip to main content
. 2020 Jul 3:10.1097/MEG.0000000000001817. doi: 10.1097/MEG.0000000000001817

Fig. 2.

Fig. 2.

Forest plots of the included studies evaluating abnormal liver chemistries among patients with COVID-19. (a) Prevalence of elevated aspartate aminotransferase. (b) Prevalence of elevated alanine aminotransferase. (c) Prevalence of elevated total bilirubin. (d) Prevalence of elevated gamma-glutamyltransferase. (e) Prevalence of elevated alkaline phosphatase. (f) Prevalence of elevated aspartate aminotransferase in patients with severe COVID-19.